Menegitis

Reading File

Finding Sources

Searching PubMed

"meningitis"[MeSH Terms] AND "diagnosis" AND "treatment"

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I have enough comprehensive information to deliver a thorough, well-structured answer. Let me compile it now.

Meningitis

Definition

Meningitis is inflammation of the arachnoid membrane, pia mater, and the intervening cerebrospinal fluid (CSF). The inflammatory process extends throughout the subarachnoid space around the brain and spinal cord, and involves the ventricles. - Goldman-Cecil Medicine

Classification

Type	Onset	Typical Organisms
Acute bacterial (pyogenic)	Hours to 1-2 days	S. pneumoniae, N. meningitidis, Listeria, H. influenzae
Viral (aseptic)	Days	Enteroviruses, HSV, herpesviruses
Subacute/Chronic	Weeks to months	M. tuberculosis, fungi (Cryptococcus, Coccidioides)
Fungal	Subacute to chronic	Cryptococcus (most common), Aspergillus, Histoplasma

Epidemiology

Incidence has dropped to ~0.5-1.5 cases/100,000 in developed countries, largely due to vaccines against H. influenzae type b, S. pneumoniae, and N. meningitidis.
S. pneumoniae now accounts for ~70% of adult bacterial meningitis cases.
Mortality remains ~15% despite treatment.
N. meningitidis predominantly affects children and young adults in close-contact settings (military barracks, college dormitories).
Listeria monocytogenes (~8% of cases) is more common in patients >50 years, diabetics, immunocompromised, and neonates.
Neonates (first 6 weeks of life): Group B Streptococcus and E. coli are key pathogens.
ROSEN's Emergency Medicine; Bradley and Daroff's Neurology in Clinical Practice

Pathogenesis

Infection typically begins with nasopharyngeal colonization. The organism invades the mucosa, enters the bloodstream, and crosses the blood-brain barrier into the CSF. Once in the CSF, host defenses are ineffective, allowing bacterial proliferation. This triggers release of cytokines, leading to:

Increased blood-brain barrier permeability
Cerebral vasculitis
Cerebral edema
Raised intracranial pressure (ICP)
Decreased cerebral blood flow -> cerebral hypoxia
ROSEN's Emergency Medicine

Clinical Features

Classic Triad: Fever + Headache + Neck stiffness (nuchal rigidity)

Full symptom profile:

Headache (severe, often described as "worst ever")
Neck stiffness / nuchal rigidity
Photophobia and phonophobia
Nausea and vomiting
Lethargy and confusion (altered mental status)
Fever

Key physical signs:

Nuchal rigidity - resistance to neck flexion
Kernig's sign - inability to extend the knee with the hip flexed
Brudzinski's sign - involuntary hip flexion when the neck is flexed
Papilledema and 6th nerve palsy (signs of raised ICP)
Maculopapular/petechial rash - classic for meningococcal disease (N. meningitidis)
Frameworks for Internal Medicine; Bradley and Daroff's Neurology

Causative Organisms by Age/Setting

Population	Common Organisms
Neonates (0-6 weeks)	Group B Streptococcus, E. coli, Listeria
Children	N. meningitidis, S. pneumoniae
Adults	S. pneumoniae, N. meningitidis
Adults >50 / immunocompromised	S. pneumoniae, Listeria monocytogenes
Post-neurosurgery / trauma	Coagulase-negative Staph, S. aureus, Pseudomonas
Immunocompromised (HIV, steroids)	Cryptococcus neoformans, M. tuberculosis

CSF Analysis (Lumbar Puncture)

The CSF profile is the cornerstone of diagnosis:

Parameter	Bacterial	Viral	Tuberculous / Fungal
Appearance	Turbid / cloudy	Clear	Clear / slightly turbid
Opening pressure	Markedly elevated	Normal / mildly elevated	Elevated
WBC	>1000/μL, PMN predominance	10-1000/μL, lymphocytic	10-500/μL, lymphocytic
Protein	Markedly elevated (>100 mg/dL)	Mildly elevated	Elevated
Glucose	Low (<45 mg/dL; CSF:serum <0.4)	Normal	Low to very low
Gram stain / Culture	Positive ~70-80%	Negative	AFB stain (20-30 mL) / PCR

A PMN count >1180 cells/μL (or >2000 WBCs/μL) has a 99% predictive value for bacterial meningitis. - Henry's Clinical Diagnosis

CT before LP is required in patients at risk for mass lesions with raised ICP (immunocompromised, papilledema, focal neurological deficits, new-onset seizures). - Frameworks for Internal Medicine

Gram Stain Characteristics of Key Organisms

Organism	Gram Stain Appearance
S. pneumoniae	Gram-positive diplococci in pairs
N. meningitidis	Gram-negative diplococci
L. monocytogenes	Gram-positive rods
H. influenzae type b	Gram-negative coccobacillus

Bradley and Daroff's Neurology in Clinical Practice

Treatment

Empiric Antibiotic Therapy (before organism identification)

Ceftriaxone 2 g IV every 12 hours OR Cefotaxime 3 g IV every 6 hours
+ Vancomycin 15-20 mg/kg IV every 8 hours (to cover resistant organisms)
+ Ampicillin 2 g IV every 4 hours - add in adults >50 years and neonates <1 month (to cover Listeria)
For hospital-acquired / post-surgical meningitis: use Cefepime 2 g IV every 8 hours (broader gram-negative cover)
For cephalosporin allergy: Meropenem or Chloramphenicol

Adjunct Therapy - Corticosteroids

Dexamethasone 0.15 mg/kg (up to 10 mg) IV every 6 hours for 4 days
First dose should be given with or 20 minutes before the first antibiotic dose
Reduces mortality in pneumococcal meningitis
Reduces incidence of hearing loss in H. influenzae meningitis
Caution: Discontinue if Listeria is identified (dexamethasone associated with worse outcomes in Listeria CNS infection)
ROSEN's Emergency Medicine

Complications

Cerebral edema and herniation
Hydrocephalus
Cerebral vasculitis / infarction
Seizures
Hearing loss (especially with H. influenzae and pneumococcal meningitis)
Waterhouse-Friderichsen syndrome (adrenal hemorrhage) - meningococcemia
Long-term neurological deficits (highest with pneumococcal meningitis)
Mortality: ~15% overall; highest with Listeria (~27%)

Fungal Meningitis (Special Note)

Most common causative organism: Cryptococcus neoformans (especially in HIV/AIDS)
Other fungi: Aspergillus, Coccidioides, Histoplasma, Blastomyces
Presentation is subacute to chronic (weeks), similar to bacterial but slower onset
CSF profile resembles TB meningitis: mononuclear pleocytosis, elevated protein, mildly low glucose
Diagnosis: Cryptococcal antigen in CSF (highly sensitive), India ink preparation, culture
Treatment: Amphotericin B + Flucytosine (induction), then Fluconazole (maintenance)
Bradley and Daroff's Neurology in Clinical Practice

Recent Evidence (2024-2026)

A 2026 Lancet Infectious Diseases clinical practice guideline for tuberculous meningitis (PMID 40840485) provides updated guidance on TB meningitis management.
A 2025 JAMA Neurology systematic review (PMID 39556369) characterized IgG4-related pachymeningitis as a distinct autoimmune cause.
A 2026 systematic review on neurocysticercosis-associated meningitis (PMID 42087630) highlights parasitic causes in endemic regions.

Summary: Meningitis is a medical emergency requiring rapid diagnosis via LP (with CT first if indicated) and immediate empiric antibiotics with dexamethasone. The clinical triad of fever, headache, and neck stiffness should prompt urgent evaluation. CSF analysis remains the diagnostic gold standard, with PMN predominance strongly favoring bacterial etiology.

This is a shared conversation. Sign in to Orris to start your own chat.